Innovotech, Inc. (IOT.V)
0.08
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 16:00
Innovotech Shareholders Equity (Quarterly) : 2.543M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.543M |
| March 31, 2026 | 3.197M |
| December 31, 2025 | 3.597M |
| September 30, 2025 | 2.749M |
| June 30, 2025 | 2.411M |
| March 31, 2025 | 2.633M |
| December 31, 2024 | 2.565M |
| September 30, 2024 | 1.002M |
| June 30, 2024 | 0.7291M |
| March 31, 2024 | 0.8296M |
| December 31, 2023 | 0.9306M |
| September 30, 2023 | 0.9364M |
| June 30, 2023 | 1.047M |
| March 31, 2023 | 0.9745M |
| December 31, 2022 | 1.058M |
| September 30, 2022 | 1.124M |
| June 30, 2022 | 1.082M |
| March 31, 2022 | 1.145M |
| December 31, 2021 | 1.177M |
| September 30, 2021 | 0.9434M |
| June 30, 2021 | 0.9648M |
| March 31, 2021 | 0.786M |
| December 31, 2020 | 0.645M |
| September 30, 2020 | 0.5761M |
| June 30, 2020 | 0.1125M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0172M |
| December 31, 2019 | 0.0981M |
| September 30, 2019 | 0.0949M |
| June 30, 2019 | 0.0757M |
| March 31, 2019 | 0.0808M |
| December 31, 2018 | 0.0935M |
| September 30, 2018 | 0.0562M |
| June 30, 2018 | 0.0729M |
| March 31, 2018 | |
| December 31, 2017 | 0.1815M |
| September 30, 2017 | -0.0978M |
| June 30, 2017 | -0.7821M |
| March 31, 2017 | -1.152M |
| December 31, 2016 | -1.218M |
| September 30, 2016 | -1.081M |
| June 30, 2016 | -1.117M |
| March 31, 2016 | -1.049M |
| December 31, 2015 | -1.003M |
| September 30, 2015 | -0.9529M |
| June 30, 2015 | -0.9057M |
| March 31, 2015 | -0.8261M |
| December 31, 2014 | -0.7657M |
| September 30, 2014 | -0.9294M |
| June 30, 2014 | -0.7993M |
| March 31, 2014 | -0.6934M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arch Biopartners, Inc. | -3.644M |
| Kane Biotech, Inc. | -1.418M |
| Quest PharmaTech, Inc. | 26.43M |
| BriaCell Therapeutics Corp. | 32.75M |
| Vaxil Bio Ltd. | 1.258M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.585M |
| Total Liabilities (Quarterly) | 0.9938M |
| Debt to Equity Ratio | 0.0642 |
| Current Ratio | 2.066 |
| Net Debt Paydown Yield | -0.71% |